At Vitsgen, We Innovate, We Create, We Make a Difference.
Innovative precision medicines for cancer patients.
We have been developing targeted radiopharmaceutical medicines to treat cancers since 2021. Vitsgen targeted radiopharmaceuticals are designed to deliver calculated doses of radiation to targeted tumors without impacting healthy tissues and vital organs.
We are changing the way cancers are treated and creating medicines for the treatment of various types of solid tumors to address unmet clinical needs.
We fully believe targeted radiopharmaceuticals have great promise to improve the lives of cancer patients.
Company Details
- Founded
- -
- Address
- Unmet Clinical Needs.
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.vitsgen.com
Vitsgen Therapeutics Inc. Questions
Vitsgen Therapeutics Inc.'s website is http://www.vitsgen.com
Vitsgen Therapeutics Inc.'s LinkedIn profile is https://www.linkedin.com/company/vitsgen
Vitsgen Therapeutics Inc.'s industry is
Biotechnology Research
Vitsgen Therapeutics Inc.'s top competitors are
山东蒂德精密机床有限公司,
Vinyash,
United Theranostics,
Y-Mabs Therapeutics, Inc.,
Viwit Pharmaceuticals,
Alpha-9 Oncology,
Eckert & Ziegler Radiopharma Inc,
Feistech International,
Rad Alliance, Inc.,
Libo Heavy Industries S & T Co., Ltd.
Vitsgen Therapeutics Inc.'s categories are Biotechnology Research
Vitsgen Therapeutics Inc.'s founding year is 2021
